Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2014 1
2016 3
2017 4
2019 4
2020 2
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Lower Body Lymphedema in Patients with Gynecologic Cancer.
Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE. Biglia N, et al. Among authors: zanfagnin v. Anticancer Res. 2017 Aug;37(8):4005-4015. doi: 10.21873/anticanres.11785. Anticancer Res. 2017. PMID: 28739682 Free article. Review.
The role of surgery in recurrent endometrial cancer.
Zanfagnin V, Ferrero A, Biglia N, Aletti G, Gill SE, Makdisi PB, Multinu F, Mariani A. Zanfagnin V, et al. Expert Rev Anticancer Ther. 2016 Jul;16(7):741-50. doi: 10.1080/14737140.2016.1190650. Epub 2016 Jun 13. Expert Rev Anticancer Ther. 2016. PMID: 27269480 Free article. Review.
Sentinel Lymph Nodes and Precision Surgery in Gynecologic Cancer.
Ghoniem K, Shazly SA, Dinoi G, Zanfagnin V, Glaser GE, Mariani A. Ghoniem K, et al. Among authors: zanfagnin v. Clin Obstet Gynecol. 2020 Mar;63(1):12-23. doi: 10.1097/GRF.0000000000000517. Clin Obstet Gynecol. 2020. PMID: 31855904 Review.
Minimally Invasive Compared With Open Surgery in High-Risk Endometrial Cancer: A Systematic Review and Meta-analysis.
Dinoi G, Ghoniem K, Murad MH, Segarra-Vidal B, Zanfagnin V, Coronado PJ, Kyrgiou M, Perrone AM, Zola P, Weaver A, McGree M, Fanfani F, Scambia G, Ramirez PT, Mariani A. Dinoi G, et al. Among authors: zanfagnin v. Obstet Gynecol. 2023 Jan 1;141(1):59-68. doi: 10.1097/AOG.0000000000004995. Epub 2022 Nov 30. Obstet Gynecol. 2023. PMID: 36701610
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma.
Kanakkanthara A, Hou X, Ekstrom TL, Zanfagnin V, Huehls AM, Kelly RL, Ding H, Larson MC, Vasmatzis G, Oberg AL, Kaufmann SH, Mansfield AS, Weroha SJ, Karnitz LM. Kanakkanthara A, et al. Among authors: zanfagnin v. Cancer Res. 2022 Jan 15;82(2):307-319. doi: 10.1158/0008-5472.CAN-21-0732. Epub 2021 Nov 22. Cancer Res. 2022. PMID: 34810199 Free PMC article.
KLF10 Mediated Epigenetic Dysregulation of Epithelial CD40/CD154 Promotes Endometriosis.
Delaney AA, Khan Z, Zheng Y, Correa LF, Zanfagnin V, Shenoy CC, Schoolmeester JK, Saadalla AM, El-Nashar S, Famuyide AO, Subramaniam M, Hawse JR, Khazaie K, Daftary GS. Delaney AA, et al. Among authors: zanfagnin v. Biol Reprod. 2016 Sep;95(3):62. doi: 10.1095/biolreprod.116.140764. Epub 2016 Aug 3. Biol Reprod. 2016. PMID: 27488034 Free PMC article.
23 results